Dataset Information


Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.

ABSTRACT: Chronic kidney disease (CKD) results in the accumulation of metabolic waste products that are normally cleared by the kidney, known as uremia. Many of these waste products are from bacteria metabolites in the gut. Accumulation of uremic toxins in plasma and tissue, as well as the gut-plasma-tissue metabolic axis are important for understanding pathophysiological mechanisms of comorbidities in CKD. In this study, an untargeted metabolomics approach was used to determine uremic toxin accumulation in plasma, liver, heart and kidney tissue in rats with adenine-induced CKD. Rats with CKD were also given AST-120, a spherical carbon adsorbent, to assess metabolic changes in plasma and tissues with the removal of gut-derived uremic toxins. AST-120 decreased >55% of metabolites that were increased in plasma, liver and heart tissue of rats with CKD. CKD was primarily defined by 8 gut-derived uremic toxins, which were significantly increased in plasma and all tissues. These metabolites were derived from aromatic amino acids and soy protein including: indoxyl sulfate, p-cresyl sulfate, hippuric acid, phenyl sulfate, pyrocatechol sulfate, 4-ethylphenyl sulfate, p-cresol glucuronide and equol 7-glucuronide. Our results highlight the importance of diet and gut-derived metabolites in the accumulation of uremic toxins and define the gut-plasma-tissue metabolic axis in CKD.


PROVIDER: S-EPMC4773761 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4520171 | BioStudies
2020-01-01 | S-EPMC7205256 | BioStudies
2020-01-01 | S-EPMC7761367 | BioStudies
2015-01-01 | S-EPMC6334305 | BioStudies
2018-01-01 | S-EPMC6070989 | BioStudies
2017-01-01 | S-EPMC5793106 | BioStudies
2020-01-01 | S-EPMC7139965 | BioStudies
1000-01-01 | S-EPMC6024790 | BioStudies
2021-01-01 | S-EPMC7917723 | BioStudies
1000-01-01 | S-EPMC5983260 | BioStudies